Skip to main content

Breadcrumb

  1. Home

Submission Tool and Repository Measure Database

As the Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE), Battelle Memorial Institute (Battelle) discloses complete information (e.g., full measure specifications, coding logic, algorithms) regarding each measure to the public for the purpose of evaluating, analyzing, or displaying of each measure for endorsement consideration. If an interested party wishes to attain complete measure information for the use and/or implementation of a measure, the interested party should contact the measure steward. Contact information for the measure steward can be found under the “Point of Contact” section of the respective measure page within the Submission Tool and Repository (STAR). Battelle is not responsible for, nor is privy to the measure use agreements that may be established between a measure steward and an interested party.

To obtain a copy of the full measure submission forms for measures endorsed prior to Fall 2022 cycle, please contact [email protected].

No Filters Selected
          CBE ID Sort descending Title Steward Endorsement Cycle Status Date of Last Endorsement Decision
          2513 Hospital 30-Day All-Cause Risk-Standardized Readmission Rate (RSRR) following Vascular Procedures Centers for Medicare & Medicaid Services Endorsement Removed
          2514 Risk-Adjusted Coronary Artery Bypass Graft (CABG) Readmission Rate The Society of Thoracic Surgeons Endorsed
          2515 Hospital 30-day, all-cause, unplanned, risk-standardized readmission rate (RSRR) following coronary artery bypass graft (CABG) surgery Centers for Medicare & Medicaid Services Endorsed
          2517 Oral Evaluation, Dental Services American Dental Association Endorsed
          2522 Rheumatoid Arthritis: Tuberculosis Screening (Recommended for eMeasure Trial Approval) American College of Rheumatology Approved for Trial Use
          2523 Rheumatoid Arthritis: Assessment of Disease Activity American College of Rheumatology Endorsed
          2524e Rheumatoid Arthritis: Patient-Reported Functional Status Assessment American College of Rheumatology Endorsed
          2525 Rheumatoid Arthritis: Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (Reccomended for eMeasure Trial Approval) American College of Rheumatology Approved for Trial Use
          2528 Prevention: Topical Fluoride for Children, Dental Services American Dental Association Endorsed
          2539 Facility 7-Day Risk-Standardized Hospital Visit Rate after Outpatient Colonoscopy Centers for Medicare & Medicaid Services